Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about LILLY DRN

Recent news which mentions LILLY DRN

< Previous 1 2 3 Next >
Novo Nordisk posts net profit beat as Wegovy sales jump 107% in fourth quarter
Tags LILLY DRN Breaking News: Europe Earnings
From CNBC.com News
Healthy Returns: Why people quit weight loss, diabetes drugs within one year
Tags Healthy Returns Health care industry Biotech and Pharmaceuticals
From CNBC.com News
5 things to know before the stock market opens Monday
Tags LILLY DRN Yum! Brands Inc General Motors Co
From CNBC.com News
Reid Hoffman enters 'wondrous and terrifying' world of health care with latest AI startup
Tags LILLY DRN Health & Science Hospitals
From CNBC.com News
Jim Cramer's week ahead: Earnings from Amazon, Alphabet, Eli Lilly, Palantir
Tags Advanced Micro Devices Inc Palantir Technologies Inc Stock markets
From CNBC.com News
FDA approves Novo Nordisk’s diabetes drug Ozempic for chronic kidney disease, expanding its use
Tags US: News Science LILLY DRN
From CNBC.com News
Food-as-medicine startups hope Kennedy, if confirmed as HHS secretary, will boost their businesses
Tags Medicare LILLY DRN Social issues
From CNBC.com News
Pharma is hopeful about Trump's second term — here's what to expect for drugmakers
Tags Breaking News: Politics GSK plc Health care industry
From CNBC.com News
'Miracle' drug innovation could see a new Wegovy launch every couple of years, Larry Summer says
Tags Breaking News: Davos Novo Nordisk A/S Pharmaceuticals
From CNBC.com News
GLP-1s and Brian Thompson’s killing loom large at top health-care conference
Tags Waystar Holding Corp IQVIA Holdings Inc Health care industry
From CNBC.com News
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
Tags Novo Nordisk A/S Pharmaceuticals Biotech and Pharmaceuticals
From CNBC.com News
Bristol Myers Squibb says Alzheimer's is the biggest market for new schizophrenia drug
Tags US: News Bristol/Myers Squibb Co Science
From CNBC.com News
Jim Cramer says he supports healthcare stocks for their long-term value
Tags U/S/ Markets Investment Strategy Mad Money
From CNBC.com News
Healthy Returns: From Eli Lilly to Amazon, here are the latest health-care deals
Tags Health care industry Pfizer Inc BridgeBio Pharma Inc
From CNBC.com News
Eli Lilly shares drop as drugmaker cuts revenue guidance on weight loss drug demand
Tags Biotech and Pharmaceuticals Health care industry Business News
From CNBC.com News
Eli Lilly CEO expects new weight loss pill to be approved next year
Tags LILLY DRN Business Health & Science
From CNBC.com News
High-cost weight loss drugs are sending employers to nutrition counseling in a boost for startups
Tags Business News Novo Nordisk A/S Pharmaceuticals
From CNBC.com News
Medicare can now cover Eli Lilly’s Zepbound for sleep apnea, CMS says
Tags LILLY DRN US: News Social issues
From CNBC.com News
Healthy Returns: The FDA approved fewer new drugs in 2024 — but some big ones hit the market
Tags Healthy Returns Madrigal Pharmaceuticals Inc Accolade Inc
From CNBC.com News
Cramer's Lightning Round: Uber is a buy
Tags Investment Strategy U/S/ Markets Investment strategy
From CNBC.com News
FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions
Tags Biotech and Pharmaceuticals Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Pharmaceuticals
From CNBC.com News
5 things to know before the stock market opens Friday
Tags Politics Markets Investment strategy
From CNBC.com News
FDA says Eli Lilly's weight loss drug Zepbound is no longer in shortage
Tags Health care industry Breaking news Companies
From CNBC.com News
Healthy Returns: A huge deal to boost Novo Nordisk's manufacturing is one step closer to closing
Tags LILLY DRN Social issues Health & Science
From CNBC.com News
Ro to offer lower-price vials of weight loss drug Zepbound by teaming up with Eli Lilly
Tags Health care industry Companies Pharmaceuticals
From CNBC.com News
The weight-loss drug boom has become one of the internet's biggest scams
Tags Meta Platforms Inc Obesity Novo Nordisk A/S
From CNBC.com News
Healthy Returns: Wall Street mulls over Amgen’s weight loss drug data
Tags Health & Science Bristol/Myers Squibb Co LILLY DRN
From CNBC.com News
Prescription fills for weight loss drugs Zepbound and Wegovy more than doubled in 2024, GoodRx says
Tags Social issues Weight management Companies
From CNBC.com News
Eli Lilly's Zepbound causes greater weight loss than Novo Nordisk's Wegovy in head-to-head trial
Tags Weight management Business Companies
From CNBC.com News
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.